126 related articles for article (PubMed ID: 10585347)
1. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.
Nakasato YR; Janckila AJ; Halleen JM; Vaananen HK; Walton SP; Yam LT
Clin Chem; 1999 Dec; 45(12):2150-7. PubMed ID: 10585347
[TBL] [Abstract][Full Text] [Related]
2. Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
Halleen JM; Karp M; Viloma S; Laaksonen P; Hellman J; Käkönen SM; Stepan JJ; Holmes S; Väänänen Hk; Pettersson K
J Bone Miner Res; 1999 Mar; 14(3):464-9. PubMed ID: 10027912
[TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies specific to human tartrate-resistant acid phosphatase.
Janckila AJ; Cardwell EM; Yam LT
Hybridoma; 1997 Apr; 16(2):175-82. PubMed ID: 9145320
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
Ohashi T; Igarashi Y; Mochizuki Y; Miura T; Inaba N; Katayama K; Tomonaga T; Nomura F
Clin Chim Acta; 2007 Feb; 376(1-2):205-12. PubMed ID: 17045980
[TBL] [Abstract][Full Text] [Related]
5. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
Halleen JM; Hentunen TA; Karp M; Käkönen SM; Pettersson K; Väänänen HK
J Bone Miner Res; 1998 Apr; 13(4):683-7. PubMed ID: 9556068
[TBL] [Abstract][Full Text] [Related]
6. Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum.
Miyazaki S; Igarashi M; Nagata A; Tominaga Y; Onodera K; Komoda T
Clin Chim Acta; 2003 Mar; 329(1-2):109-15. PubMed ID: 12589973
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isoenzyme in serum.
Chamberlain P; Compston J; Cox TM; Hayman AR; Imrie RC; Reynolds K; Holmes SD
Clin Chem; 1995 Oct; 41(10):1495-9. PubMed ID: 7586523
[TBL] [Abstract][Full Text] [Related]
8. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
9. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
[TBL] [Abstract][Full Text] [Related]
10. Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase.
Janckila AJ; Walton SP; Yam LT
Biotech Histochem; 1998 Nov; 73(6):316-24. PubMed ID: 9888357
[TBL] [Abstract][Full Text] [Related]
11. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Janckila AJ; Simons RM; Yam LT
Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
[TBL] [Abstract][Full Text] [Related]
12. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
Takahashi K; Janckila AJ; Sun SZ; Lederer ED; Ray PC; Yam LT
Clin Chim Acta; 2000 Nov; 301(1-2):147-58. PubMed ID: 11020469
[TBL] [Abstract][Full Text] [Related]
13. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
14. Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
J Bone Miner Res; 2001 Apr; 16(4):788-93. PubMed ID: 11316008
[TBL] [Abstract][Full Text] [Related]
15. Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase.
Pradella SD; Slone SP; Wu YY; Chao TY; Parthasarathy RN; Yam LT; Janckila AJ
J Immunol Methods; 2011 Sep; 372(1-2):162-70. PubMed ID: 21787778
[TBL] [Abstract][Full Text] [Related]
16. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
[TBL] [Abstract][Full Text] [Related]
17. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
[TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry.
Ballanti P; Minisola S; Pacitti MT; Scarnecchia L; Rosso R; Mazzuoli GF; Bonucci E
Osteoporos Int; 1997; 7(1):39-43. PubMed ID: 9102061
[TBL] [Abstract][Full Text] [Related]
19. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
